Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Progress in Biomaterials is Scopus-indexed (Q1, CiteScore 9.2), WoS SCIE. Published by OICC Press.
Checked against the index lists dated .
ISSN 2194-0509Verify ISSN ↗2194-0517Verify ISSN ↗
Publisher: OICC Press
Cost to publish: About US$3,090 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Chemical Engineering (miscellaneous) | 22 / 106 | 79th | Q1 |
| Biomaterials | 39 / 146 | 73rd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q1, CiteScore 9.2.
Progress in Biomaterials is Q1 in Chemical Engineering (miscellaneous) (rank 22 of 106) and Q2 in Biomaterials (rank 39 of 146), by CiteScore 2025.
Progress in Biomaterials is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9.2, which places it in quartile Q1 at the 79th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.918, quartile Q1, with an H-index of 45.
The publisher lists an article processing charge of about US$3,090 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Progress in Biomaterials is published by OICC Press. Its print ISSN is 2194-0509 and its online ISSN is 2194-0517.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Progress in Biomaterials has an h-index of 52 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 9.2, quartile Q1. On 2-year citations it ranks #87 of 98 Scopus journals in Chemical Engineering (miscellaneous).
Progress in Biomaterials published 6 papers in 2023; its busiest recent year was 2022 with 38. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 66 research articles (2021–2023), authors are most often from Iran (40.5%), India (27.5%) and Bangladesh (3.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.